Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Immunodiagnostics Market reach by 2030 starting from 2026 levels?

The immunodiagnostics market has experienced robust growth recently. This market is projected to expand from $24.32 billion in 2025 to $26.16 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.5%. Historically, this expansion has been driven by factors such as the increasing prevalence of infectious and chronic diseases, the broadening of clinical laboratory networks, a rising need for early disease detection, the increased adoption of antibody-based diagnostics, and the availability of standardized immunoassay technologies.

The immunodiagnostics market is expected to witness substantial growth in the coming years, projected to reach $35.76 billion by 2030, reflecting a compound annual growth rate (CAGR) of 8.1%. This expansion during the forecast period is primarily due to the increasing adoption of personalized diagnostics, growing investments in automated laboratories, the broadening scope of point-of-care immunodiagnostics, enhanced integration of AI-based result interpretation, and a heightened focus on preventive healthcare testing. Key trends influencing the market over this period include the increasing adoption of automated immunoassay analyzers, a rising demand for high-sensitivity diagnostic tests, the expanding use of rapid immunodiagnostic kits, an increase in multiplex testing capabilities, and improved integration of laboratory data management systems.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10093&type=smp

Which Drivers Are Influencing Long-Term Growth In The Immunodiagnostics Market?

The growing prevalence of chronic illnesses is projected to stimulate the expansion of the immunodiagnostics market in the future. Chronic diseases are long-term medical conditions that typically progress slowly, including diabetes, heart disease, and arthritis, often requiring ongoing medical care and lifestyle management to control symptoms and avert complications. The increase in chronic diseases is largely due to unhealthy lifestyles, encompassing poor diet, physical inactivity, and smoking, which heighten the risk of conditions such as diabetes, heart disease, and obesity. Immunodiagnostics support chronic disease diagnosis by allowing for the accurate identification of biomarkers and immune responses linked to long-term health issues. They improve the early detection and monitoring of conditions like diabetes, autoimmune disorders, and cardiovascular diseases, thereby enhancing patient management and aiding prompt treatment decisions. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Consequently, the rising incidence of chronic and infectious diseases is driving the growth of the immunodiagnostics market.

How Is The Immunodiagnostics Market Divided Into Segments?

The immunodiagnostics market covered in this report is segmented –

1) By Product: Reagents And Consumables, Instruments

2) By Technology: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Rapid Test, Other Technologies

3) By Application: Infectious Diseases, Oncology And Endocrinology, Bone And Mineral Diseases, Autoimmunity Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications

4) By End User: Hospitals, Clinics, Diagnostic Laboratories

Subsegments:

1) By Reagents And Consumables: Antibodies, Assay Kits, Buffers And Substrates

2) By Instruments: Immunoassay Analyzers, ELISA Readers

Which Trends Are Influencing The Performance And Direction Of The Immunodiagnostics Market?

Major companies operating in the immunodiagnostics market are increasingly focusing on developing innovative solutions, such as automated chemiluminescence immunoassays (CLIAs), to enhance diagnostic accuracy, reduce testing time, and improve laboratory efficiency. Automated chemiluminescence immunoassays (CLIAs) are laboratory tests that utilize light-emitting chemical reactions and automation to quickly and accurately detect specific proteins or antibodies in blood or other samples. For instance, in September 2025, DiaSorin S.p.A., an Italy-based diagnostics company, launched the LIAISON® TSH-R Ab assay for autoimmune thyroid disorder assessment. The test introduces features such as enhanced antibody specificity through double-bridge assay architecture, seamless integration into existing LIAISON analyzers to streamline laboratory workflows, and CE-marked compatibility supporting deployment across multiple regulated regions.

Which Key Market Players Are Investing In Expansion And Innovation Within The Immunodiagnostics Market?

Major companies operating in the immunodiagnostics market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., bioMérieux SA, Sysmex Corporation, Becton Dickinson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Fujirebio Holdings Inc., Quidel Corporation, Luminex Corporation, Bio-Techne Corporation, PerkinElmer Inc., Merck KGaA, Gold Standard Diagnostics Corp., OraSure Technologies Inc., Immunodiagnostic Systems Holdings Plc (IDS)

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

Which Regions Are Poised For Strategic Growth In The Immunodiagnostics Market?

North America was the largest region in the immunodiagnostics market in 2025. The regions covered in the immunodiagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Immunodiagnostics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10093&type=smp

Browse Through More Reports Similar to the Global Immunodiagnostics Market 2026, By The Business Research Company

Immunohematology Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunoassay Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Automated Immunoassay Analyzers Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/automated-immunoassay-analyzers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company